Review of PCR e-course 2020 late-breaking clinical trials

dc.creatorMedranda, Giorgio A.
dc.creatorYerasi, Charan
dc.creatorCase, Brian C.
dc.creatorForrestal, Brian J.
dc.creatorChezar-Azerrad, Chava
dc.creatorWermers, Jason P.
dc.creatorWaksman, Ron
dc.date.accessioned2020-08-07T14:32:55Z
dc.date.accessioned2022-09-23T18:27:05Z
dc.date.available2020-08-07T14:32:55Z
dc.date.available2022-09-23T18:27:05Z
dc.date.created2020-08-07T14:32:55Z
dc.identifier1553-8389
dc.identifierhttps://doi.org/10.1016/j.carrev.2020.07.022
dc.identifierhttp://hdl.handle.net/20.500.12010/11741
dc.identifierhttps://doi.org/10.1016/j.carrev.2020.07.022
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/3501137
dc.description.abstractSince 1989, the Paris Course of Revascularisation (PCR) has shared expertise and experience in cardiovascular medicine with healthcare professionals around the world. This year, EuroPCR was canceled because of the COVID -19 pandemic. In its place, the PCR e -Course was held to offer the latest cardiovascular science and an opportunity for interventional cardiologists to interact with, and learn from, experts and peers around the world
dc.publisherCardiovascular Revascularization Medicine
dc.rightsinfo:eu-repo/semantics/embargoedAccess
dc.rightsAcceso restringido
dc.sourcereponame:Expeditio Repositorio Institucional UJTL
dc.sourceinstname:Universidad de Bogotá Jorge Tadeo Lozano
dc.subjectCOVID -19
dc.subjectPandemic
dc.subjectPCR e -Course
dc.titleReview of PCR e-course 2020 late-breaking clinical trials


Este ítem pertenece a la siguiente institución